Literature DB >> 24594221

Execution of control among 'non-compliant', imprisoned individuals in opioid maintenance treatment.

Ingrid Amalia Havnes1, Thomas Clausen2, Anne-Lise Middelthon3.   

Abstract

Strict control routines of prescribed opiate intake in opioid maintenance treatment, OMT, are used to reduce the risk of diversion and non-prescribed methadone and buprenorphine use. While maintaining a focus on aspects of control, this article explores motivations for and practices of methadone and buprenorphine use, both inside and outside of prison and among imprisoned individuals in OMT. The participants in this qualitative study were subjected to tight external control regimes in their opioid maintenance schemes in prison, as they were prior to imprisonment due to varying degrees of 'non-compliance'. We nevertheless found them to exhibit a considerable amount of self-control, self-regulation and/or self-initiation of external control. Among the participants, a ceaseless surveillance of processes associated with methadone and buprenorphine use throughout diverse situations, relations and contexts was encountered. We conclude that, in opioid maintenance treatment, some individuals might know what particular configurations of internal and external control they need in order to achieve their own treatment goals. The drug users' capacities for execution of control, as well as their delegations of control to others, may be seen as resources throughout the course of treatment.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diversion; OMT; Pharmacological agency; Prison; Self-control; Self-regulation

Mesh:

Substances:

Year:  2014        PMID: 24594221     DOI: 10.1016/j.drugpo.2014.01.018

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  1 in total

1.  The role of substance use and morality in violent crime - a qualitative study among imprisoned individuals in opioid maintenance treatment.

Authors:  Ingrid Amalia Havnes; Thomas Clausen; Christina Brux; Anne-Lise Middelthon
Journal:  Harm Reduct J       Date:  2014-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.